dc.contributor.author | Aksoy Sağırlı, Pınar | |
dc.contributor.author | Altıparmak Ülbegi, Gülsüm | |
dc.contributor.author | Can, Ayşe | |
dc.contributor.author | Hasbal Çelikok, Gözde | |
dc.date.accessioned | 2021-02-28T14:23:03Z | |
dc.date.available | 2021-02-28T14:23:03Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Hasbal Çelikok G., Aksoy Sağırlı P., Altıparmak Ülbegi G., Can A., "Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment", Oncology Letters, cilt.21, ss.1-10, 2021 | |
dc.identifier.issn | 1792-1074 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e9c4de3f-a392-4ec2-8c35-71d1a1de3a88 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/1404 | |
dc.identifier.uri | https://doi.org/10.3892/ol.2021.12470 | |
dc.identifier.uri | https://avesis.istanbul.edu.tr/api/publication/e9c4de3f-a392-4ec2-8c35-71d1a1de3a88/file | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.title | Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment | |
dc.type | Makale | |
dc.relation.journal | Oncology Letters | |
dc.contributor.department | İstanbul Üniversitesi, Eczacılık Fakültesi, Biyokimya Anabilim Dalı | |
dc.identifier.volume | 21 | |
dc.identifier.issue | 209 | |
dc.identifier.startpage | 1 | |
dc.identifier.endpage | 10 | |
dc.contributor.firstauthorID | 2507347 | |